Main Conference: 26 – 27 September 2018
Pre-Conference Workshops: 25 September 2018
Copthorne Tara Hotel, London, UK

Immuno-Oncology is a fast-paced field with massive potential to deliver successful and durable cancer therapies.

SMi's Immuno-Oncology Conference will focus on a few key areas of the field with representation of the whole industry, under each area. These areas will be drawn together to look towards the future of Immuno-oncology and how the field can progress.


At the SMi's Immuno-Oncology Conference participants will get:

Agenda - Valuable time is spent to discover the latest trends and hottest topics in the industry to provide the best possible agenda for attendees. 15+ engaging presentations/case studies/keynote addresses, including:

  • Targeting immune checkpoints with Humabody VH therapeutics
  • Recent advances in providing durable disease control with Keytruda as an anti-cancer therapy
  • Tumour mutation burden and the potential of its use as an indication of treatment choice
  • Unwanted immunogenicity and functionality testing of immuno-oncology drugs
  • New techniques, such as the emerging applications of liquid biopsies, in Immuno-Oncology


Speakers - Top representation of industry leaders. 15+ leading experts in Immuno-Oncology field, including

  • James Legg, Vice President R&D, Crescendo Biologics
  • Andrew Exley, Medical Assessor, MHRA
  • Harry Smith, Medical Scientist, Gilead Sciences
  • Grace Macaulay, Global Safety Physician Patient Safety Oncology, MedImmune
  • David Giljohan, CEO, Exicure
  • Kandeepan Ganeshalingam, Executive Director, Oncology Therapeutic Area Head, European Clinical Development, MSD
  • Rochana Wickramasinghe, Director of Oncology Evaluation, AstraZeneca


Workshops - Carefully selected topics for further on-sight training. 2 pre-conference workshops to provide in-depth knowledge on specific topics:

  • Strategic Competitive Intelligence in the Immuno-Oncology space - hosted by LucidQuest Ventures
  • Could the Microbiome boost Cancer Immuno-Therapy - hosted by ImmuneBiotech and Lund University


Networking - it is at the forefront of SMi events. 5+ hours of pure networking guaranteed. Follow event updates to be in the know about who will be joining the conversation.


To view detailed information about event programme, speaker line-up and workshop agenda visit website


Twitter - @SMIpharm & #immunooncologysmi

LinkedIn - SMi Pharma



+44 (0)20 7827 6000

profile mask

Lyudmyla Durneva

25 April, 2018